Updated:
Whiteoak
Whiteoak has partners including Richard Whiteoak, Greg Garvin, Lorcan Barden, and Udhav Goenka who serve as Managing Directors. The firm also has principals...
Whiteoak
Whiteoak has partners including Richard Whiteoak, Greg Garvin, Lorcan Barden, and Udhav Goenka who serve as Managing Directors. The firm also has principals such as Jason Wu and Oliver Kirkland who serve as Investment Directors.
General information
Firm type
Private Equity
Year founded
2010
Location
Region
Oceania
Country
Australia
City
Sydney
Corporate office
Sydney, Australia
Principals
Gregory Jones
Managing Partner
Graham Whitehead
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Whiteoak?
Managing Partner Gregory Jones and Partner Graham Whitehead lead the investment committee and oversee all deal origination, execution, and portfolio management. Both co-founded the firm in 2010 and are the primary decision-makers on new investments and exits. Their backgrounds in Australian institutional private equity and investment banking shape the firm's operationally focused investment approach.
How does Whiteoak source its deals?
Whiteoak sources transactions through a network of founder-level relationships, Australian corporate advisors, and accounting firms serving privately held businesses. The firm focuses on proprietary and limited-auction processes where its ability to navigate complex ownership transitions — particularly family successions — provides a competitive advantage. The firm's lower-mid-market focus screens out most large-scale auction processes conducted by global investment banks.
Does Whiteoak invest outside Australia and New Zealand?
Whiteoak's mandate is restricted to Australia and New Zealand. The firm has completed transactions in both countries, applying its buy-and-build and operational improvement strategy across the trans-Tasman market. There is no public record of investments outside this geography.
Which sectors does Whiteoak explicitly avoid?
Whiteoak does not invest in resources, mining services, or pure-play commodities — sectors it has stated are inconsistent with its operational-value-creation approach and desired risk profile. The firm also avoids early-stage technology businesses, biotech, and real estate development, concentrating instead on business services, industrial technology, healthcare services, and select consumer verticals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: